|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07F 9/6561 | (2006.01) |
| C07F 9/65616 | (2013.01) | ||
| A61K 31/685 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 31/20 | (2006.01) | ||
| A61P 31/20 | (2018.01) |
| (11) | Number of the document | 3577125 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18705239.4 |
| Date of filing the European patent application | 2018-01-29 | |
| (97) | Date of publication of the European application | 2019-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/015770 |
| Date | 2018-01-29 |
| (87) | Number | WO 2018/144390 |
| Date | 2018-08-09 |
| (30) | Number | Date | Country code |
| 201762452428 P | 2017-01-31 | US |
| (72) |
LAI, Chiajen , US
SHI, Bing , US
STRICKLEY, Robert, G. , US
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE |
| CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE |